Login / Signup

Staging Disease Severity Using the Alzheimer's Disease Composite Score (ADCOMS): A Retrospective Data Analysis.

Amir Abbas Tahami MonfaredKatherine HoughtonQuanwu ZhangJosephine Mauskopfnull null
Published in: Neurology and therapy (2022)
ADCOMS values ranges can be used to assess the severity of cognitive decline. The derived severity threshold score ranges for ADCOMS will enable its use as an endpoint in clinical trials assessing disease progression and clinical outcomes of disease-modifying therapies in persons with MCI or early AD, including patients with Aβ + confirmation.
Keyphrases
  • cognitive decline
  • data analysis
  • mild cognitive impairment
  • clinical trial
  • lymph node
  • pet ct
  • randomized controlled trial
  • phase ii